Stock News•1 week ago
Establishment Labs: Procedure Economics Strengthens The Bull Case
Establishment Labs' Q2 2026 revenue rose 31.7%, with gross margin expanding to 70.6%, after FDA approval and U.S. entry boosted procedure-based sales. U.S.
MarketLens
Is Evolus (EOLS) Finally Turning the Corner on Profitability
4 months ago
SHARE THIS ON:
Exclusive Content for Pro Members
Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.
SHARE THIS ON:
Related Articles
Category
You may also like
Stock News•3 weeks ago
Wall Street Analysts Think Evolus (EOLS) Could Surge 77.68%: Read This Before Placing a Bet
Evolus (EOLS) could surge 77.7% per the mean analyst price target, after analysts raised earnings estimates with strong agreement, signaling potential upside.
Stock News•1 months ago
e.l.f. Stock Hasn't Given Investors a Lot to Cheer About Lately. Here's Why That Could Change.
e.l.f. Beauty stock has underperformed recently, but upcoming growth catalysts could shift sentiment.
Breaking News
View All →Featured Articles
Top Headlines
Stock News•43 minutes ago
Inside Microsoft and OpenAI, Worry About Damaging the Publishing Industry
Stock News•50 minutes ago
ASUS and Poesis Team Up on Autonomous Trading Agents Powered by NVIDIA Technologies
Stock News•51 minutes ago
Amazon-owned Zoox's 100-robotaxi limit in Nevada is about to disappear
Stock News•1 hour ago
Why Alphabet Inc. (GOOG) Outpaced the Stock Market Today
Stock News•1 hour ago